Radiomics of Immunotherapeutics Response Evaluation and Prediction

Clinical trial NCT04079283 · COMPLETED

Trial details

NCT number: NCT04079283
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Solid Tumor Predictive Cancer Model

Start date: 2017-01-01
Primary completion: 2019-12-31
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.